ISRCTN48397858已完成不适用
A randomised trial of maintenance weekly paclitaxel versus observation following remission with first-line induction carboplatin and paclitaxel for patients with ovarian cancer
The Institute of Cancer Research (UK)0 个研究点目标入组 1,200 人开始时间: 2002年10月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Histologically confirmed epithelial ovarian cancer, fallopian tube cancer and primary peritoneal cancer
- •2. Female, aged 18 years and over
- •3. International Federation of Gynecology and Obstetrics (FIGO) stage III to IV. Receive six cycles of carboplatin/paclitaxel, three-weekly at registration
- •4. Able to complete quality of life questionnaires
- •5. Can comply with follow-up requirements. Written informed consent
- •6. Response to induction treatment (as demonstrated by a Computed Tomography [CT] scan)
排除标准
- •1. Patients with peritoneal carcinomatosis of 'uncertain' origin which is mucin-secreting
- •2. Histological evidence of an origin in the gastrointestinal tract, bilary system or lung
研究者
相似试验
进行中（未招募）
1 期
CTRG B09/00 A phase I/II study of weekly paclitaxel, UFT, and leucovorin in patients with metastatic breast cancerCancer - BreastMetastatic breast cancerACTRN12605000464662CTRG initiated study60
尚未招募
2 期
ow dose cancer drugs for advanced stomach cancerCTRI/2022/11/047033JIPMER PONDICHERRY
招募中
2 期
Improving Performance status of Advanced lung cancer patients with ChemotherapyCTRI/2020/01/022617All India Institute of Medical Sciences
已完成
2 期
Assessment of efficacy of weekly paclitaxel chemotherapy in ovarian cancersAdvanced Ovarian Cancer.Malignant neoplasm of ovaryIRCT2017050333789N1Taleghani Hospital- Shahid Beheshti University of Medical Sciences14
进行中（未招募）
不适用
Weekly maintainance therapy with Paclitaxel vs control arm after first line chemotherapy in patients with metastatic breast carcinoma. Phase III multicentric clinical trial.breast cancerEUCTR2004-004031-59-ITAZIENDA OSPEDALIERA POLICLINICO DI MODENA